Jnk1 in murine hepatic stellate cells is a crucial mediator of liver fibrogenesis

Gut

Volumn 63, Issue 7, 2014, Pages 1159-1172

  Zhao, Gang ^a   Hatting, Maximilian ^a   Nevzorova, Yulia A ^a   Peng, Jin ^a   Hu, Wei ^a   Boekschoten, Mark V ^b   Roskams, Tania ^c   Muller, Michael ^b   Gassler, Nikolaus ^a   Liedtke, Christian ^a   Davis, Roger J ^d   Cubero, Francisco Javier ^a   Trautwein, Christian ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA SMOOTH MUSCLE ACTIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; COLLAGEN IA1; COLLAGEN TYPE 1; STRESS ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL DEATH; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; FIBROGENESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER FIBROSIS; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STELLATE CELL;

CELL SIGNALLING; CHOLESTATIC LIVER DISEASES; DRUG INDUCED HEPATOTOXICITY; FIBROGENESIS; INFLAMMATION;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; BONE MARROW TRANSPLANTATION; CELL TRANSDIFFERENTIATION; CHRONIC DISEASE; DOWN-REGULATION; HEPATIC STELLATE CELLS; HEPATOCYTES; HUMANS; LIVER CIRRHOSIS; MALE; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 8; UP-REGULATION;

EID: 84902295999     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-305507     Document Type: Article

References (36)

1. Oakley F, Teoh V, Ching ASG, et al. Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosis. Gastroenterology 2009;136:2334-44 e1.
2. Kluwe J, Pradere JP, Gwak GY, et al. Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition. Gastroenterology 2010;138:347-59.
3. Iredale JP. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 2007;117:539-48. (Pubitemid 46348508)
4. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008;134:1655-69. (Pubitemid 351615417)
5. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125-72.
6. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 2000;103:239-52.
7. Yoshida K, Matsuzaki K, Mori S, et al. Transforming growth factor-beta and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury. Am J Pathol 2005;166:1029-39. (Pubitemid 40524428)
8. Postic C, Shiota M, Niswender KD, et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem 1999;274:305-15. (Pubitemid 29035064)
9. Das M, Jiang F, Sluss HK, et al. Suppression of p53-dependent senescence by the JNK signal transduction pathway. Proc Natl Acad Sci U S A 2007;104:15759-64. (Pubitemid 350035373)
10. Dong C, Yang DD, Wysk M, et al. Defective T cell differentiation in the absence of Jnk1. Science 1998;282:2092-5. (Pubitemid 29001267)
11. Seki E, Brenner DA, Karin M. A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology 2012;143:307-20.
12. Toivola DM, Ku NO, Resurreccion EZ, et al. Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease. Hepatology 2004;40:459-66. (Pubitemid 39062864)
13. Louis H, Van Laethem JL, Wu W, et al. Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology 1998;28:1607-15. (Pubitemid 28549131)
14. Tacke F, Weiskirchen R. Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques. Expert Rev Gastroenterol Hepatol 2012;6:67-80.
15. Constandinou C, Henderson N, Iredale JP. Modeling liver fibrosis in rodents. Methods Mol Med 2005;117:237-50.
16. Tsukamoto H, Matsuoka M, French SW. Experimental models of hepatic fibrosis: A review. Semin Liver Dis 1990;10:56-65. (Pubitemid 20163706)
17. Das M, Sabio G, Jiang F, et al. Induction of hepatitis by JNK-mediated expression of TNF-alpha. Cell 2009;136:249-60.
18. Schwabe RF, Brenner DA. Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 2006;290:G583-9.
19. Ni HM, Chen X, Ding WX, et al. Differential roles of JNK in ConA/GalN and ConA-induced liver injury in mice. Am J Pathol 2008;173:962-72.
20. Weston CR, Davis RJ. The JNK signal transduction pathway. Curr Opin Genet Dev 2002;12:14-21. (Pubitemid 34094984)
21. Chang L, Kamata H, Solinas G, et al. The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 2006;124:601-13. (Pubitemid 43199444)
22. Schattenberg JM, Singh R, Wang Y, et al. JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology 2006;43:163-72. (Pubitemid 43733603)
23. abio G, Cavanagh-Kyros J, Ko HJ, et al. Prevention of steatosis by hepatic JNK1. Cell Metab 2009;10:491-8.
24. Hui L, Zatloukal K, Scheuch H, et al. Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation. J Clin Invest 2008;118:3943-53.
25. De Smaele E, Zazzeroni F, Papa S, et al. Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature 2001;414:308-13. (Pubitemid 33097807)
26. Liu X, Kim CN, Yang J, et al. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 1996;86:147-57. (Pubitemid 26256586)
27. Natoli G, Costanzo A, Ianni A, et al. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 1997;275:200-3.
28. Tang G, Minemoto Y, Dibling B, et al. Inhibition of JNK activation through NF-kappaB target genes. Nature 2001;414:313-7. (Pubitemid 33097808)
29. Wicovsky A, Muller N, Daryab N, et al. Sustained JNK activation in response to tumor necrosis factor is mediated by caspases in a cell type-specific manner. J Biol Chem 2007;282:2174-83. (Pubitemid 47076782)
30. Krause D, Lyons A, Fennelly C, et al. Transient activation of Jun N-terminal kinases and protection from apoptosis by the insulin-like growth factor I receptor can be suppressed by dicumarol. J Biol Chem 2001;276:19244-52.
31. Alcorn JF, van der Velden J, Brown AL, et al. c-Jun N-terminal kinase 1 is required for the development of pulmonary fibrosis. Am J Respir Cell Mol Biol 2009;40:422-32.
32. Ma FY, Flanc RS, Tesch GH, et al. A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis. J Am Soc Nephrol 2007;18:472-84. (Pubitemid 46193313)
33. Solinas G, Vilcu C, Neels JG, et al. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab 2007;6:386-97. (Pubitemid 350012000)
34. Kodama Y, Kisseleva T, Iwaisako K, et al. c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice. Gastroenterology 2009;137:1467-77 e5.
35. Kodama T, Takehara T, Hikita H, et al. Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice. J Clin Invest 2011;121:3343-56.
36. Nevzorova YA, Bangen JM, Hu W, et al. Cyclin E1 controls proliferation of hepatic stellate cells and is essential for liver fibrogenesis in mice. Hepatology 2012;56:1140-9.